Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Angina pectoris
ADR ID BADD_A00228
ADR Hierarchy
02      Cardiac disorders
02.02      Coronary artery disorders
02.02.02      Ischaemic coronary artery disorders
02.02.02.002      Angina pectoris
24      Vascular disorders
24.04      Arteriosclerosis, stenosis, vascular insufficiency and necrosis
24.04.04      Coronary necrosis and vascular insufficiency
24.04.04.002      Angina pectoris
Description The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. [MeSH]
MedDRA Code 10002383
MeSH ID D000787; D060050
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Angina | Angina aggravated | Angina attack | Angina of effort | Angina on exercise | Angina pectoris | Angina pectoris aggravated | Angina symptom | Angina syndrome | Angina worsened | Anginal attack | Anginal pain | Anginal syndrome | Cardialgia | Chest pain - cardiac | Effort angina | Elsner's asthma | Exercise induced angina | Heberden's angina | Increased angina | Other and unspecified angina pectoris | Rougnon-Heberden disease | Stenocardia | Stable angina pectoris | Anginal discomfort | Cardiac pain | Ischaemic chest pain | Ischemic chest pain | Atypical angina | Refractory angina pectoris | Angina pectoris recurrent | New onset angina pectoris | Angina pectoris CCS class II | Angina pectoris CCS class III | Angina pectoris CCS class I | Angina pectoris CCS class IV | Intermittent angina pectoris | Angina Pectoris | Stenocardias | Angor Pectoris
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02259Trandolapril--
BADD_D02260Trandolaprilat--
BADD_D02261Tranexamic acid--
BADD_D02265Travoprost--
BADD_D02305Trospium--
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02314Umeclidinium0.000299%
BADD_D02321Ursodiol--
BADD_D02325Valdecoxib--
BADD_D02329Valproic acid0.000419%
BADD_D02331Valsartan0.000185%
BADD_D02335Vardenafil--
BADD_D02336Vardenafil hydrochloride--
BADD_D02337Varenicline0.000720%
BADD_D02338Varenicline tartrate--
BADD_D02339Vasopressin--
BADD_D02340Vasopressin tannate--
BADD_D02344Vemurafenib0.000224%
BADD_D02346Venlafaxine0.000048%
BADD_D02348Verapamil--
BADD_D02349Verapamil hydrochloride--
BADD_D02358Vinblastine--
BADD_D02359Vinblastine sulfate--
BADD_D02364Vinorelbine tartrate--
BADD_D02367Voltaren--
BADD_D02371Vortioxetine0.000296%
BADD_D02373Warfarin--
BADD_D02375Water--
BADD_D02379Zaleplon--
The 16th Page    First    Pre   16 17    Next   Last    Total 17 Pages
ADReCS-Target
ADR Term Drug Name Target